Introducing a new type of alternative laryngeal mucosa model

• Published in: PloS one 2023-06, Vol.18 (6), p.e0287634-e0287634
• Main Authors: Grossmann, Tanja, Kirsch, Andrijana, Grill, Magdalena, Steffan, Barbara, Karbiener, Michael, Brcic, Luka, Darnhofer, Barbara, Birner-Gruenberger, Ruth, Gugatschka, Markus
• Format: Article
• Language: English
• Subjects: Availability; Biology; Biology and Life Sciences; Biopsy; Buccal mucosa; Care and treatment; Cell culture; Cicatrix; Collagen; Collagen (type IV); Diagnosis; Epithelial cells; Epithelium; Experiments; Fibroblasts; Health aspects; Humans; In vivo methods and tests; Laryngeal diseases; Laryngeal Mucosa; Larynx; Medicine and Health Sciences; Modelling; Multilayers; Polymerase chain reaction; Proteins; Proteomics
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0287634

Research of human vocal fold (VF) biology is hampered by several factors. The sensitive microstructure of the VF mucosa is one of them and limits the in vivo research, as biopsies carry a very high risk of scarring. A laryngeal organotypic model consisting of VF epithelial cells and VF fibroblasts (VFF) may overcome some of these limitations. In contrast to human VFF, which are available in several forms, availability of VF epithelial cells is scarce. Buccal mucosa might be a good alternative source for epithelial cells, as it is easily accessible, and biopsies heal without scarring. For this project, we thus generated alternative constructs consisting of immortalized human VF fibroblasts and primary human buccal epithelial cells. The constructs (n = 3) were compared to native laryngeal mucosa at the histological and proteomic level. The engineered constructs reassembled into a mucosa-like structure after a cultivation period of 35 days. Immunohistochemical staining confirmed a multi-layered stratified epithelium, a collagen type IV positive barrier-like structure resembling the basement membrane, and an underlying layer containing VFF. Proteomic analysis resulted in a total number of 1961 identified and quantified proteins. Of these, 83.8% were detected in both native VF and constructs, with only 53 proteins having significantly different abundance. 15.3% of detected proteins were identified in native VF mucosa only, most likely due to endothelial, immune and muscle cells within the VF samples, while 0.9% were found only in the constructs. Based on easily available cell sources, we demonstrate that our laryngeal mucosa model shares many characteristics with native VF mucosa. It provides an alternative and reproducible in vitro model and offers many research opportunities ranging from the study of VF biology to the testing of interventions (e.g. drug testing).